CT/NG検査市場：製品タイプ、技術、エンドユーザー別-2025-2030年の世界予測

CT/NG検査市場は、2023年に16億3,000万米ドルと評価され、2024年には17億4,000万米ドルに達すると予測され、CAGR 7.41％で成長し、2030年には26億9,000万米ドルに達すると予測されています。

クラミジア・トラコマティスと淋菌スクリーニングを含むCT/NG検査市場は、STD罹患率の上昇と公衆衛生意識の高まりにより注目されています。これらの細菌感染症は、未治療の感染症が深刻な生殖に関する健康問題につながる可能性があるため、極めて重要な検査対象です。CT/NG検査の必要性は、早期診断と予防における重要性からきており、ヘルスケアコストの削減と公衆衛生の安全性の促進に直接影響します。主に病院、診療所、診断ラボで適用されるこれらの検査は、性的に活発な人々に対応しており、プライバシーや利便性の要因から家庭用検査キットでの採用が増加しています。市場の成長は、分子診断学の技術的進歩、政府の保健イニシアティブ、包括的な性的健康製品に対する需要の高まりによって大きく促進されます。主な成長機会は、費用対効果が高く高感度なポイントオブケア検査機器の開発が中心です。地域別に見ると、新興諸国はヘルスケアインフラの整備や疾病啓発キャンペーンの増加により、大きな成長機会を提供しています。しかし、高度な検査技術の高額な費用や、STD検査に関連する社会文化的な偏見といった要因によって成長が阻害され、保守的な地域での普及が妨げられる可能性があります。技術革新の展望は、迅速検査法の強化、検出精度の向上、バイオテクノロジーの進歩によるコスト削減にあります。さらに、人工知能や機械学習を診断プロセスに組み込むことで、臨床現場におけるデータ精度と業務効率を向上させ、市場提供に革命をもたらす可能性があります。企業は、ヘルスケアプロバイダーやテクノロジー企業との戦略的協業により、未浸透地域へのアクセスと認知度の拡大から利益を得ることができます。市場力学は、ヘルスケアの優先順位の変化や技術の進歩によって左右されるダイナミックな性質を持っているため、新たな機会を活用し、内在する課題を克服するためには、継続的な市場調査とイノベーションが不可欠です。

市場力学：急速に進化するCT/NG検査市場の主要市場インサイトを公開

CT/NG検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のSTI有病率の増加
  • 未治療の感染症がもたらす結果に対する意識の高まり
  • ポイントオブケア（POC）検査機器に対するニーズの高まり
• 市場抑制要因
  • 高度な診断機器に伴う高コスト
• 市場機会
  • 性的健康教育を推進する政府の取り組み
  • ワークフロー効率を高めるための自動化システムの統合
• 市場の課題
  • CT/NG検査による抗生物質耐性株の出現

ポーターのファイブフォース：CT/NG検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、CT/NG検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：CT/NG検査市場における外部からの影響の把握

外部マクロ環境要因は、CT/NG検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析CT/NG検査市場における競合情勢の把握

CT/NG検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCT/NG検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、CT/NG検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨CT/NG検査市場における成功への道筋を描く

CT/NG検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で性感染症の蔓延が増加
    • 未治療の感染症の影響についての認識が高まる
    • ポイントオブケア（POC）検査機器の需要の高まり
  • 抑制要因
    • 高度な診断機器に関連する高コスト
  • 機会
    • 性教育を推進するための政府の取り組み
    • ワークフローの効率を高める自動化システムの統合
  • 課題
    • 抗生物質耐性菌の出現by CT/NG検査
• 市場セグメンテーション分析
  • 製品：一貫した結果を提供するための機器と分析装置の迅速な導入
  • テストの種類：CT/NGのPoCテストの人気が高まっている
  • テクノロジー：コストとスピードよりも精度を優先するポリメラーゼ連鎖反応（PCR）ベースのCT/NG検査の進化
  • エンドユーザー：病院や診療所でのポイントオブケア検査の人気
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 CT/NG検査市場：製品別

• アッセイとキット
• 計測機器と分析装置

第7章 CT/NG検査市場テストの種類別

• ラボテスト
• PoCテスト

第8章 CT/NG検査市場：技術別

• 免疫診断
• 等温核酸増幅技術
• ポリメラーゼ連鎖反応

第9章 CT/NG検査市場：エンドユーザー別

• 臨床検査室
• 病院・クリニック

第10章 南北アメリカのCT/NG検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のCT/NG検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのCT/NG検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • binx healthはAfaxysとの戦略的供給契約を発表し、全国の何千ものクリニックに性健康検査へのアクセスを拡大します。
  • バイオ・ラッド、Exact Diagnostics CT/NG、STI Run Controlsを発売
  • アボット社、性感染症（STI）の症例増加を受け、4つの一般的な性感染症を同時に検出する初の検査でFDAの認可を取得
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Binx Health, Inc.
• Bio-Rad Laboratories, Inc.
• Bioneer Corporation
• Danaher Corporation
• ELITech Group SAS
• F. Hoffmann-La Roche Ltd.
• Geneproof A.S.
• Genetic Signatures Ltd.
• Goffin Molecular Technologies B.V.
• Hologic, Inc.
• Meridian Bioscience Inc.
• Microbiologics, Inc.
• Molbio Diagnostics Pvt. Ltd.
• Operon S.A.
• PerkinElmer Inc.
• QIAGEN N.V.
• Sansure Biotech Inc.
• Seegene, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Tianlong Technology Co., Ltd.
• Vircell S.L.
• Visby Medical, Inc.

LIST OF FIGURES

• FIGURE 1. CT/NG TESTING MARKET RESEARCH PROCESS
• FIGURE 2. CT/NG TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CT/NG TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CT/NG TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY POC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. CHINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. INDIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. INDIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. ITALY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. ITALY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ITALY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. POLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. POLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. POLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. QATAR CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. QATAR CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. QATAR CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 189. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The CT/NG Testing Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.74 billion in 2024, and is projected to grow at a CAGR of 7.41%, to USD 2.69 billion by 2030.

The CT/NG testing market, encompassing Chlamydia trachomatis and Neisseria gonorrhoeae screening, has gained prominence due to rising STD incidences and heightened public health awareness. These bacterial infections are crucial testing targets as untreated infections can lead to severe reproductive health issues. The necessity of CT/NG testing stems from its significance in early diagnosis and prevention, directly influencing healthcare cost reductions and promoting public health safety. Predominantly applied in hospitals, clinics, and diagnostic labs, these tests cater to sexually active populations, with increasing adoption in home-testing kits due to privacy and convenience factors. Market growth is significantly fueled by technological advancements in molecular diagnostics, governmental health initiatives, and rising demand for comprehensive sexual health products. Key growth opportunities are centered around the development of cost-effective and highly sensitive point-of-care testing devices. Delving into regional perspectives, developing countries offer substantial growth windows due to emerging healthcare infrastructures and increasing disease awareness campaigns. However, growth is challenged by factors like high costs of advanced testing technologies and socio-cultural stigmas associated with STD testing, potentially hindering widespread acceptance in conservative regions. Innovation prospects lie in the enhancement of rapid testing methods, improving detection accuracy, and cost reductions through biotechnology advancements. Furthermore, integrating artificial intelligence and machine learning in diagnostic processes may revolutionize market offerings by improving data accuracy and operational efficiencies in clinical settings. Businesses can benefit from strategic collaborations with healthcare providers and technology firms to expand access and awareness across under-penetrated regions. The CT/NG testing market is underlined by its dynamic nature, dictated by shifting healthcare priorities and technological progression, making continual market research and innovation essential for capitalizing on emerging opportunities and overcoming inherent challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CT/NG Testing Market

The CT/NG Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of STIs worldwide
  • Growing awareness about the consequences of untreated infections
  • Rising need for point-of-care (POC) testing devices
• Market Restraints
  • High costs associated with advanced diagnostic equipment
• Market Opportunities
  • Government initiatives for promoting sexual health education
  • Integration of automation systems to enhance workflow efficiency
• Market Challenges
  • Emergence of antibiotic-resistant strains by CT/NG testing

Porter's Five Forces: A Strategic Tool for Navigating the CT/NG Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CT/NG Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CT/NG Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CT/NG Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CT/NG Testing Market

A detailed market share analysis in the CT/NG Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CT/NG Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CT/NG Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CT/NG Testing Market

A strategic analysis of the CT/NG Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CT/NG Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Danaher Corporation, ELITech Group SAS, F. Hoffmann-La Roche Ltd., Geneproof A.S., Genetic Signatures Ltd., Goffin Molecular Technologies B.V., Hologic, Inc., Meridian Bioscience Inc., Microbiologics, Inc., Molbio Diagnostics Pvt. Ltd., Operon S.A., PerkinElmer Inc., QIAGEN N.V., Sansure Biotech Inc., Seegene, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tianlong Technology Co., Ltd., Vircell S.L., and Visby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the CT/NG Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Assays & Kits and Instruments & Analyzers.
• Based on Testing Type, market is studied across Lab Tests and PoC Tests.
• Based on Technology, market is studied across Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology, and Polymerase Chain Reaction.
• Based on End User, market is studied across Clinical Laboratories and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of STIs worldwide
    • 5.1.1.2. Growing awareness about the consequences of untreated infections
    • 5.1.1.3. Rising need for point-of-care (POC) testing devices
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with advanced diagnostic equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives for promoting sexual health education
    • 5.1.3.2. Integration of automation systems to enhance workflow efficiency
  • 5.1.4. Challenges
    • 5.1.4.1. Emergence of antibiotic-resistant strains by CT/NG testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rapid adoption of instruments and analyzers for providing consistent results
  • 5.2.2. Testing Type: Gaining popularity of PoC tests for CT/NG
  • 5.2.3. Technology: Advancing Polymerase Chain Reaction (PCR)-based CT/NG testing for prioritizing accuracy over cost and speed
  • 5.2.4. End User: Popularity of point-of-care testing for hospital and clinic settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. CT/NG Testing Market, by Product

• 6.1. Introduction
• 6.2. Assays & Kits
• 6.3. Instruments & Analyzers

7. CT/NG Testing Market, by Testing Type

• 7.1. Introduction
• 7.2. Lab Tests
• 7.3. PoC Tests

8. CT/NG Testing Market, by Technology

• 8.1. Introduction
• 8.2. Immunodiagnostics
• 8.3. Isothermal Nucleic Acid Amplification Technology
• 8.4. Polymerase Chain Reaction

9. CT/NG Testing Market, by End User

• 9.1. Introduction
• 9.2. Clinical Laboratories
• 9.3. Hospitals & Clinics

10. Americas CT/NG Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific CT/NG Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa CT/NG Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally
  • 13.3.2. Bio-Rad Launches Exact Diagnostics CT/NG, STI Run Controls
  • 13.3.3. Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Binx Health, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Bioneer Corporation
• 6. Danaher Corporation
• 7. ELITech Group SAS
• 8. F. Hoffmann-La Roche Ltd.
• 9. Geneproof A.S.
• 10. Genetic Signatures Ltd.
• 11. Goffin Molecular Technologies B.V.
• 12. Hologic, Inc.
• 13. Meridian Bioscience Inc.
• 14. Microbiologics, Inc.
• 15. Molbio Diagnostics Pvt. Ltd.
• 16. Operon S.A.
• 17. PerkinElmer Inc.
• 18. QIAGEN N.V.
• 19. Sansure Biotech Inc.
• 20. Seegene, Inc.
• 21. Siemens Healthineers AG
• 22. Thermo Fisher Scientific Inc.
• 23. Tianlong Technology Co., Ltd.
• 24. Vircell S.L.
• 25. Visby Medical, Inc.